The seasonal influenza A vaccine is recommended for patients with myeloproliferative neoplasms (MPNs).  We hypothesised that immune deregulation associated with MPNs may affect the immune response gained following vaccinations when compared to healthy controls. Using deep immunophenotyping with high‐dimensional single‐cell analysis and mass cytometry we could demonstrate an altered immune response in MPN patients following […]